New study to reveal hidden fertility risks of breast cancer immunotherapy

NCT ID NCT07527819

First seen Apr 17, 2026 · Last updated May 15, 2026 · Updated 3 times

Summary

This study looks at how chemotherapy combined with immunotherapy affects the ovaries and fertility in women with early-stage triple-negative breast cancer. Researchers will track hormone levels, menstrual patterns, and ovarian function for up to two years after treatment. No new treatments are given—participants receive standard cancer care. The goal is to better understand the risks to ovarian health so doctors can offer better advice about fertility preservation.

Disclaimer Read more

This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for TRIPLE-NEGATIVE BREAST CANCER (TNBC) are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Contacts and locations

Study contacts

  • Contact

    Phone: •••-•••-•••• Email: •••••@•••••

  • Contact

    Phone: •••-•••-•••• Email: •••••@•••••

Locations

  • Chris O'Brien Lifehouse

    Camperdown, New South Wales, 2050, Australia

    Contact Email: •••••@•••••

    Contact

  • Eastern Health

    Box Hill, Victoria, 3128, Australia

    Contact Email: •••••@•••••

    Contact

  • Icon Cancer Centre

    Hobart, Tasmania, 7000, Australia

    Contact Email: •••••@•••••

    Contact

  • Lyell McEwin Hospital

    Adelaide, South Australia, 5112, Australia

    Contact Email: •••••@•••••

    Contact

  • Mater Hospital Sydney

    Sydney, New South Wales, 2060, Australia

    Contact Email: •••••@•••••

    Contact

  • Monash Health

    Clayton, Victoria, 3168, Australia

    Contact Email: •••••@•••••

    Contact

  • Peter MacCallum Cancer Centre

    Melbourne, Victoria, 3000, Australia

    Contact Email: •••••@•••••

    Contact

  • Royal Melbourne Hospital

    Melbourne, Victoria, 3052, Australia

    Contact Email: •••••@•••••

    Contact

  • Sir Charles Gairdner Hospital

    Nedlands, Washington, 6009, Australia

    Contact Email: •••••@•••••

    Contact

Conditions

Explore the condition pages connected to this study.